Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Boosting Brand Growth Now In
Emerging Markets
Kurt KesslerKurt Kessler
How can we boost brand growth nowin emerging markets?
• Emerging markets offer attractive growth today
• Globalization forces have pushed to near simultaneous worldwide launches
Situation
• Growth imperative
• Lack of resources
• “Variation” problem
• How can Marketing Research professionals efficiently identify and structure initiatives to boost growth of existing brands in emerging markets –right now?
Key Question
Complications
There are consistent portfolio, product, and internal planning challenges in our industry
Portfolio and Environment Complexity
Product Launch and Patent Loss
Resource Allocation
Organizational Challenges
Our suggested approach is creative and analytical, taking participants in emerging markets out of their normal environment to
create practical solutions to these challenges
The objective is to find profitable incremental sales opportunities over and above current brand spending
Current State Desired State
Rev
enue
s
TimeExisting Plan
Rev
enue
s
Time“Max” Plan
• Profitable upsides• Innovative ideas• Specific action
plans
• Average or slow growth
• Lack of new ideas• Business-as-usual
Desirable features of an approach to resolving these challenges include…
• Provide structures to frame the challenges complemented by light analytics that work but do not overwhelm the process
• Make the identification of growth initiatives an effort outside the day-to-day
• Identify those initiatives with the highest return and develop a feasible action plan
• Build on the current brand planning process
Balance depth and breadth
Inspire creativity
Prioritize resources
Minimize effort
How can we efficiently develop and implement business plans in emerging markets for our cardiovascular portfolio –and deliver on the growth imperative?
• PharmaCo has four cardiovascular brands in markets across the globe
• Asian and Latin American markets have experienced slower growth than hoped
• Organizational elements in place for many of these markets, but resources and expertise are limited
Situation• Global HQ mandates higher growth
targets than can be attained through ‘business as usual’
• Limited time to show progress on the ideas that will drive growth upward
• Need to identify cost effective approaches that can work across the entire region rather than only for single countries
Complications
€€
Though beginning and ending at the regional level, much of the work to create solutions lies at the country level
Country
Guidelines
Local Team Preparation
Initiatives
for Each Product
Portfolio Analysis & Action Plan
Region HQ
Global HQPortfolio Analysis
& Action Plan
Timing was adjusted to have results in hand to complement the annual brand planning process
Within each country and for each brand in the portfolio, we engaged local affiliates in a four step process
Assign responsibilities and resources
to execute
Prioritize limited
resources into the most promising initiatives
Unrestrained imagination of initiatives to capture the
value
Identify additional sources of
upsides and opportunities
INVESTIGATE CREATE EVALUATE PLAN
Market Company
Within each country and for each brand in the portfolio, we engaged local affiliates in a four step process
INVESTIGATE CREATE EVALUATE PLAN
Workshop 1
3 days
Refine
2-4 weeks
Workshop 2
3 days
Country Business
Plan
Affiliate with Support Affiliate
Simple frameworks supported by easy-to-use tools help the teams view their market with a new perspective and identify new opportunities
INVESTIGATEWhere can we find a potential upside?
?
Future
Interaction & Synergies
W
X
Y
V
Z
Indication
Channel
Customer
Patient
LifecycleBrands
Patient Flow AnalysisMarket Influence Map
Stakeholders
Compliance
Our Brand
Pharmaceutical
Diagnosis
Screening
For example, in several markets for one of the brands, the same strategic objectives were identified through a light patient flow analysis
Strategic Objectives
Expand the market through increased diagnosis
Increase treatment with a pharmaceutical
Patients Lost
Leve
rage
Poi
nts
INVESTIGATEPatient Flow Analysis
The next step is to brainstorm initiatives aligned with each strategic objective to seize the opportunity
Prioritized strategicobjectives
Benchmarks & innovativeideas from other
products/countries
Cross-functionaldialogue
FacilitatedBrainstorming
Initiatives for Evaluation
CREATE
CREATE
For example, many country-specific initiatives were identified that aligned with the strategic objectives
Strategic Objective Initiative 1 Initiative 2 Initiative 3…
Expand the market through increased
diagnosis
Public Awareness Campaign
Conduct public awareness campaign regarding the disease prevalence to motivate patients to seek blood
screening and diagnosis
KOL Diagnosis Initiative
Leverage relationships with KOLs to develop educational content / programs and create leadership regarding
disease diagnosis
CVD Long Term StudyConduct long-term study of potential patients not
yet displaying CVD symptoms to identify
common factors / characteristics that lead to CVD among country
population
Increase treatment with a
pharmaceutical
Treatment Guideline Development
Work with government to develop revised
treatment guidelines to encourage earlier
treatment with a drug
Educational CampaignCampaign to prescribers educating as to why and when to move beyond
“diet and exercise” and to a drug in the treatment of
the disease
Clinical ComparisonConduct a retrospective
analysis of in-country patients on our brand vs.
traditional herbal remedies to support use
in more patients
EVALUATE
The evaluation step begins with defining more explicitly the what and how of each initiative
?????
Stakeholders?
StrategicObjective?
TacticalObjective?
Targets?
Upside €?
Cost €?
Next Steps?
EVALUATE
Each initiative is now a more tangible idea to be evaluated and prioritized
Strategic Objective Expand the market through increased diagnosis
Initiative 1 Initiative 2 … Notes
Tactical Objective Drive to seek treatment
Drive to diagnose more
Description Awareness Campaign
KOL Diagnosis Initiative
Target General public Physicians
Upside € €25MM €15MM Use simple models to estimate
Cost € €10MM €2MM Rough estimate to be refined later
Next StepsEvaluate
feasibility with key partners
Medical review on the core
content
EVALUATE
All of the initiatives are ultimately prioritized atthe country level, and later at a regional level
Cumulative increase in NPV(€MM)
Initiative% Return ROI
Initiative Cost (€MM)
For each initiative that passes the evaluation screen, a plan of action is developed
PLANTimeline with Milestones
Executive Consulted Informed Consulted
Marketing Accountable Accountable Accountable
Marketing Research Responsible Responsible Informed
Sales Consulted Informed
Medical Consulted Informed Consulted
Responsibilities
Rolled out through the countries, the region nowhas a set of initiatives to fuel the growth
Country
Initiatives Evaluated
Initiatives Approved
Ecuador2112
Chile2710
Singapore45
Taiwan3212
Hong Kong5721
28
Columbia3715
Argentina2811
Brazil2411
Malaysia3421
China198
Korea6422
Japan2616
The approach can be applied to a wide variety of company situations in emerging markets
Number of Brands
Example: Six brands in one portfolio optimized with a cross functional
50 person team
Example: one brand analyzed across
multiple countries
Example: Two brands in emerging markets
optimized through cross-functional workshops
Analyticdepth
Example: one brand analyzed in depth leveraging
multiple data sources for fine
tuning of the marketing mix
Example: Three brands analyzed across
multiple emerging market countries
leveraging available data to challenge
current investment plan
Several key factors must be managed toensure success
MindsetWe can do it!
ProcessEvents that foster
creativity and balance with practicality
ToolsA fair balance
between simplicity and sophistication
DataAppropriate data
to help make better decisions
DialogueAccess and leverage the
expertise
Each of these are required at a reasonable level –The others cannot compensate if any one is far out of balance